RecruitingNot ApplicableNCT05407168

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

Sponsor

OHSU Knight Cancer Institute

Enrollment

300 participants

Start Date

Oct 31, 2022

Study Type

INTERVENTIONAL

Conditions

Lung Carcinoma

Summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing a simple conversation tool to help people with suspected lung cancer better understand their treatment options and make decisions that align with their values and preferences, even if they have low health literacy. **You may be eligible if...** - You have suspected lung cancer - You speak English fluently - You have a life expectancy of more than 6 months - You pass a brief cognitive screening (score of 3 or above) - You are involved in discussions about lung cancer treatment decisions **You may NOT be eligible if...** - You have significant cognitive impairment - You do not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.